Crucial US Advisory Committee to Cast Ballots on Changing Baby Hepatitis B Vaccine Advisory
Following a delay and a remarkably divisive gathering, a government vaccine expert group was set to cast ballots on Friday concerning altering the long-held guideline that each baby be inoculated against hepatitis B.
Heated Debate and a Postponed Decision
The first day of the assembly on Thursday was defined by fiery discussion over restricting access to the hepatitis B vaccine for newborns and a resolution to postpone the decision by a day to provide committee members extra time to examine the language. The committee, which advises the Centers for Disease Control and Prevention on immunization practices, had previously delayed on two occasions.
“Is there any specific evidence of damage of giving this shot before 30 days? Or is this speculation?” questioned one committee member.
In reply, another participant stated, “There is inadequate data about the prolonged hazard.”
Current Guidelines and Potential Impact
The shot is currently recommended for every newborn within 24 hours of birth to halt contraction of hepatitis B, which can lead to significant hepatic injury. It has been administered to 1.4 billion people for in excess of thirty years.
The meeting in Atlanta presented no recent proof of harms caused by the vaccine. Specialists note any modification to the present hepatitis B immunization timeline could have profound and widespread repercussions for infant and child health in the United States.
Committee Makeup and Latest Shifts
The advisory panel can only make recommendations to the head of the CDC. The committee's composition has seen shifts in recent days, with the statement that the panel's latest chairman would step down for an official role and be replaced by a cardiologist who has been critical of other immunizations.
The board includes multiple vaccination critics who support a desire to overhaul – and perhaps, in some cases, abolish – longstanding vaccine advisories.
